From: Role of tight junction proteins in gastroesophageal reflux disease
Panel A Transcript level | Gene expression/ß-actin (a.u.) median (range) | Changevs. controls (x-fold) | P-values (* Kruskal-Wallis; posthoc: Man WhitneyUtest) |
---|---|---|---|
Occludin | Â | Â | 0.098* |
controls | 0.041 (0.0086 - 0.38) | Â | Â |
NERD | 0.060 (0.0052 - 0.57) | 1.46 | n.a. |
ERD | 0.035 (0.0026 - 1.09) | 0.85 | n.a. |
Claudin-1 | Â | Â | 0.0097* |
controls | 0.078 (0.0072 - 2.54) | Â | Â |
NERD | 0.15 (0.012 - 1.6) | 1.92 | 0.016 |
ERD | 0.20 (0–4.1) | 2.56 | 0.0032 |
Claudin-2 | Â | Â | 0.0027* |
controls | 0.000038 (0–0.003) |  |  |
NERD | 0.0002 (0–0.019) | 5.26 | 0.0041 |
ERD | 0.000083 (0–0.021) | 2.18 | 0.11 |
ZO-1 | Â | Â | 0.069* |
controls | 0.0060 (0.0012 - 0.073) | Â | Â |
NERD | 0.0081 (0–0.067) | 1.35 | n.a. |
ERD | 0.0077 (0.0015 - 0.21) | 1.28 | n.a. |
ZO-2 | Â | Â | 0.061* |
controls | 0.011 (0.0022 - 0.038) | Â | Â |
NERD | 0.019 (0.002 - 0.27) | 1.72 | n.a. |
ERD | 0.021 (0.0019 - 0.59) | 1.9 | n.a. |
Panel B Protein level | IHC score median (range) | Change (x-fold) vs. controls | P -values (* Kruskal-Wallis; posthoc: Man Whitney U test) |
Occludin | Â | Â | 0.02* |
controls | 3 (1 – 9) |  | - |
NERD | 6 (1 – 15) | 2.0 | 0.026 |
ERD | 8 (1 – 12) | 2.7 | 0.012 |
Claudin-1 | Â | Â | 0.014* |
controls | 1 (1 – 4) |  | - |
NERD | 2 (1 – 9) | 2.0 | 0.14 |
ERD | 6 (1 – 8) | 6.0 | 0.0004 |
Claudin-2 | Â | Â | 0.0057* |
controls | 4 (1 – 9) |  | - |
NERD | 6 (1 – 12) | 1.5 | 0.28 |
ERD | 9 (4 –15) | 2.25 | 0.0025 |
ZO-1 | Â | Â | 0.62* |
controls | 2 (0 – 6) |  | - |
NERD | 4 (1 –12) | 2.0 | n.a. |
ERD | 3 (0 – 3) | 1.5 | n.a. |
ZO-2 | Â | Â | 0.58* |
controls | 4 (0 – 10) |  | - |
NERD | 4 (0 – 8) | 1.0 | n.a. |
ERD | 1 (0 – 8) | 0.25 | n.a. |